Literature DB >> 7741034

Histamine as an autocrine growth factor in experimental mammary carcinomas.

G P Cricco1, C A Davio, G Martin, N Engel, C P Fitzsimons, R M Bergoc, E S Rivera.   

Abstract

In order to determine the role of endogenous histamine in the regulation of cell growth, the in vitro action of fluoromethyl-histidine (MFMH) was studied in experimental mammary carcinomas induced in rats. Tumor cells were cultured in soft agar using the clonogenic agar technique. The MFMH was added in different concentrations (0.01-100 microM). The effect observed was a 60% inhibition on colony formation with a maximal effect at concentrations over 10 microM. This action was completely reverted by the H2 agonists dimaprit and arpromidine with an IC50 value of 1 microM. The action of the H2 agonists when added alone was a significant increase in cell proliferation (135%), while the H1 agonist produced a dose-dependent inhibition on cell growth. In these experimental carcinomas endogenous histamine is critical for cell proliferation and one of its major effects may be the stimulation of cell growth by acting on specific H2 membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7741034     DOI: 10.1007/BF02005757

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

Review 1.  Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase.

Authors:  T Watanabe; A Yamatodani; K Maeyama; H Wada
Journal:  Trends Pharmacol Sci       Date:  1990-09       Impact factor: 14.819

Review 2.  G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation.

Authors:  W H Moolenaar
Journal:  Cell Growth Differ       Date:  1991-07

3.  The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver.

Authors:  L J Brandes; J R Davie; F Paraskevas; B Sukhu; R P Bogdanovic; F S LaBella
Journal:  Agents Actions Suppl       Date:  1991

Review 4.  Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

Authors:  Y S Cho-Chung
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

5.  Changes in histamine synthesis, tissue content and catabolism in human breast cancer.

Authors:  M Garcia-Caballero; E Neugebauer; F Rodriguez; I Nuñez de Castro; A Heredia; E Oosting; C Vara Thorbeck
Journal:  Agents Actions       Date:  1989-04

6.  The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture.

Authors:  K Uçar
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

7.  Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.

Authors:  J Bartholeyns; M Bouclier
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

8.  Histamine receptors in an experimental mammary carcinoma.

Authors:  E S Rivera; C A Davio; A Venturino; R A Caro; R M Bergoc
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529

9.  Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors.

Authors:  B C Tilly; L G Tertoolen; R Remorie; A Ladoux; I Verlaan; S W de Laat; W H Moolenaar
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

  9 in total
  12 in total

1.  Up-regulation of histidine decarboxylase expression and histamine content in B16F10 murine melanoma cells.

Authors:  Steven C Davis; Sheena Clark; J Robert Hayes; Todd L Green; Carl A Gruetter
Journal:  Inflamm Res       Date:  2010-07-18       Impact factor: 4.575

2.  Histamine regulates the expression of histidine decarboxylase in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats.

Authors:  N Engel; G Cricco; C Davio; G Martin; M Croci; C Fitzsimons; R Bergoc; E Rivera
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

3.  HDC gene polymorphisms are associated with age at natural menopause in Caucasian women.

Authors:  Feng Zhang; Dong-Hai Xiong; Wei Wang; Hui Shen; Peng Xiao; Fang Yang; Robert R Recker; Hong-Wen Deng
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

4.  Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas.

Authors:  C Davio; A Baldi; A Mladovan; G Cricco; C Fitzsimons; R Bergoc; E Rivera
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

Review 5.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

Authors:  L T Van der Ven; S C Van Buul-Offers; T Gloudemans; P J Roholl; J S Sussenbach; W Den Otter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?

Authors:  P F Bowrey; J King; C Magarey; P Schwartz; P Marr; E Bolton; D L Morris
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Lack of Association between rs2067474 Polymorphism in Histamine Receptor H2 Gene and Breast Cancer in Chinese Han Population.

Authors:  Wen-Ke Cai; Jia-Bin Zhang; Niu-Min Wang; Ying-Lin Wang; Can-Hu Zhao; Jun Lu; Gong-Hao He
Journal:  ScientificWorldJournal       Date:  2015-04-02

9.  A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.

Authors:  Aldo Segura-Cabrera; Reshmi Tripathi; Xiaoyi Zhang; Lin Gui; Tsui-Fen Chou; Kakajan Komurov
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

10.  Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.

Authors:  Ava Vila-Leahey; Sharon A Oldford; Paola A Marignani; Jun Wang; Ian D Haidl; Jean S Marshall
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.